B
one marrow (BM) transplantation models have vital importance in studying immunological tolerance and clinical therapies for hematopoietic disorders and cancer.
Standard mixed BM chimeras are used to evaluate the development and function of the immune system, where donor BM cells are genetically manipulated and engrafted into syngeneic, allogeneic, or immunocompromised recipients, including NOD/SCID (1) or RAG/g c (2) mice. Clinically, cellular transplantation has expanded from a treatment for immunodeficient and chemotherapy patients to adoptive cell-mediated immune therapy for combatting malignant cells. Adoptive therapies take advantage of the graft-versustumor effect (3), a regimen inspired by clinical graft-versus-host disease (4) . Hematopoietic transplant success depends upon the minimization of immunological graft rejection and the maximization of donor stem cell reconstitution. Although transplantation of healthy hematopoietic cells could be beneficial to patients, their immune systems actively prevent efficient engraftment of allogeneic transplants.
A major obstacle preventing BM transplant reconstitution is the presence of host NK cell activity. The importance of NK cells in BM graft rejection surfaced when "hybrid resistance" was reported. Hybrid resistance occurs when F1 hybrid offspring of two MHC-disparate mouse strains reject or are resistant to BM grafts derived from either parent (5) (6) (7) (8) . The mechanism behind hybrid resistance is postulated to stem from "missing-self" recognition of one of two codominantly expressed parental MHC-I haplotypes (e.g., H-2 b or H-2 d alleles in [C57BL/6xBALB/c]F 1 mice), which are independently sensed by F 1 NK cell subsets expressing nonoverlapping inhibitory self-MHC-I-specific Ly49 receptor repertoires. During development, F 1 NK cells are "educated" to express a Ly49 receptor repertoire specific for, and tolerant to, both self-MHC-I haplotypes (9) (10) (11) ; however, because NK receptor expression is variegated, at least four overarching categories can be described: NK subsets expressing an inhibitory Ly49 specific for either H-2 d or H-2 b alleles, a subset expressing Ly49 specific for both H-2 d and H-2 b alleles, and a subset expressing neither class of Ly49 receptor. Thus, parental (H-2 b/b or H-2 d/d ) BM cells transplanted into an F 1 (H-2 b/d ) host are perceived to be "missing" at least one self MHC-I allele by NK cell subsets rendered tolerant to non-overlapping allelic specificities. At the molecular level, F 1 inhibitory Ly49 receptors that recognize only H-2 b or H-2 d alleles are not engaged; hence, missing-self recognition ensues, leading to selective rejection of parental BM grafts. Hybrid resistance is one of the earliest phenomena delineating a unique role for NK cells in determining BM transplant rejection (8, 12, 13) . Further evidence came from observations in which allogeneic BM cells engraft in NK-depleted hosts (14) (15) (16) yet are rejected by C.B-17/ SCID recipients (17, 18) (which lack B and T lymphocytes but possess intact NK cell activity) (19) .
Nonetheless, MHC-independent NK recognition mechanisms have recently emerged, including the NKR-P1B:Clr-b receptorligand pair. In rats, viral evasion of this system determines the outcome of viral titers during rat CMV-English infection (RCMV-E; Mhv-8) (20, 21) . Briefly, RCMV-infected cells lose surface expression of host Clr-b-like rat Clec2d11, yet RCMV-E encodes an NKR-P1B-specific decoy, RCTL, that functionally replaces Clec2d11 and inhibits NK cells. In addition, mouse tumor lines and stressed cells also lose expression of Clr-b (22, 23) , thereby augmenting their susceptibility to NK cells. These findings broaden the significance of MHC-independent NK cell immunosurveillance in the discrimination of pathological versus healthy target cells.
In this study, we investigated whether this system plays a nonredundant role in normal self-nonself discrimination during autologous and allogeneic hematopoietic transplants. Specifically, we assessed the selective rejection of Clr-b 2/2 BM cells in comparison with wild-type (WT) and various MHC-I-deficient BM cells, using a competitive in vivo transplantation assay. We show that Clr-b 2/2 BM cells are selectively and acutely rejected by B6 and allogeneic recipients in an NK cell-dependent manner, mediated specifically by the NKR-P1B hi NK cell subset. Furthermore, Clr-b 2/2 NK cells are functionally hyporesponsive, similar to MHC-I-deficient NK cells. These results support the importance of MHC-independent mechanisms in regulating hematopoietic transplant rejection and NK cell function in vivo.
Materials and Methods

Cells
BWZ.36 and P815 cells were obtained from Drs. Nilabh Shastri and David Raulet (University of California, Berkeley, Berkeley, CA). BWZ.CD3z/ NKR-P1B, BWZ.Clr-b cells were generated previously (22, 24) . Cells were cultured in complete DMEM-high glucose, supplemented with 2 mM glutamine, 100 U/ml penicillin, 100 mg/ml streptomycin, 50 mg/ml gentamicin, 110 mg/ml sodium pyruvate, 50 mM 2-ME, 10 mM HEPES, and 10-20% FCS. Mouse tissues were processed into single-cell suspensions using 40-mm filters (BD Biosciences), ACK Lysing Buffer (Life Technologies), and/or Lympholyte (Cedarlane). Solid organs were processed using gentleMACS (Miltenyi Biotec ; Clec2d 2/2 ) mice were described previously (26) . B6.Nkrp1b B62/2 mice were generated as described (27) 
RT-PCR and quantitative RT-PCR
Tissue RNA was isolated using an RNA Purification Kit (Invitrogen) and reverse transcribed using oligo-dT primer and a SuperScript III cDNA Synthesis Kit (Invitrogen) (22, 23) . Semiquantitative RT-PCR was performed using 50-125 ng of template cDNA, Expand PLUS High Fidelity enzyme (Roche), and primers in Table I . PCR products were cloned (pcDNA3.1/TOPO; Invitrogen) and sequenced. Real-time quantitative RT-PCR (qRT-PCR) was performed on a CFX-96 Real-Time PCR Detection System (Bio-Rad) using 50-100 ng of template cDNA, SsoFast EvaGreen Supermix (Bio-Rad), and primers in Table I . Data were analyzed using CFX Manager software.
Abs
Abs were purchased from eBioscience, BD Pharmingen, Sigma-Aldrich, or BioLegend, except Clr-b mAb, 4A6 (22) , and NKR-P1B B6 mAb, 2D12 (28) . The mAb clones are as follows: NKG2D (MI6); Ly49C/I/F/H (14B11); Ly49C/I (5E6); Ly49H (3D10); Ly49I (YLI-90); Ly49D (4E5); Ly-6G/Gr-1 (RB6-8C5); FLAG (M2); CD19 (ID3); H-2K b (AF6-88. 
Flow cytometry
Cells were FcR blocked on ice for 10 min using 2.4G2 supernatant, stained with primary mAb for 25 min, and washed and stained for 20 min with secondary streptavidin conjugates. Intracellular staining, fixation, and permeabilization used Cytofix/Cytoperm (BD Biosciences), as well as IFN-g Ab (30 min in 13 Perm/Wash). Cells were analyzed using an LSRII (BD Biosciences) and FlowJo software (TreeStar). DAPI exclusion was used for live cell viability.
Competitive BM rejection assay
Donor cells from various animals were singly or combinatorially labeled using PKH26, PKH67 (Sigma-Aldrich), and/or CellVue Maroon (eBioscience) (Table II) Percent engraftment of experimental donor cells relative to control WT or syngeneic donor cells was determined as follows:
Reporter cell assays BWZ cells were retrovirally transduced with CD3z/NKR-P1 constructs and sorted for GFP + cells, as described (22, 24) . Reporter cells (10 5 per well) were incubated with serial 3-fold titrations of stimulator cells overnight. Control reporter cells were stimulated with 10 ng/ml PMA and 0.5 mM ionomycin. Cells were washed, resuspended in 100 ml of 13 
Chromium release assay
Cytotoxicity assays were performed as described (22) . Splenic lymphokineactivated killer (LAK) effector cells were cultured in 10% complete RPMI 1640 plus 2500 U/ml human rIL-2 (Proleukin; Novartis) for a total of 6 d. On day 4, these cells were FACS sorted for NKp46 + and NKR-P1B + expression and used as effectors in 51 Cr-release assays. Target cells (10 7 /ml) were incubated with 100 mCi Na 2 51 CrO 4 (PerkinElmer) in FCS at 37˚C for 1 h, washed, and plated (round-bottom) in serial titrations with effector cells (3-5 3 10 5 per microliter) at 37˚C for 4 h. Supernatants (100 ml) were transferred to scintillation plates (PerkinElmer), dried overnight, and counted using a Top Count NXT Microplate Scintillation Counter (Packard Instrument Company). Percent specific lysis values were calculated relative to maximum release (2% Nonidet P-40) and spontaneous release (media) values.
IFN-g assays
Splenocytes were cultured in 96-well Immulon plates, with either platebound PK136 mAb or 5 ng/ml IL-18 (R&D Systems) plus IL-12 (PeproTech), for 5 h in the presence of GolgiStop and GolgiPlug (BD Biosciences). Cells were then stained for surface markers, fixed, permeabilized, and stained intracellularly for IFN-g.
Results
Phenotypic and functional characterization of Clr-b 2/2 mice B6.Ocil/Clr-b 2/2 (hereafter, Clr-b 2/2 ) mice exhibit a mild defect in osteoclast development and function (26) . These animals were generated directly on a B6 background (verified by Illumina genotyping) by targeted deletion of exon-3 of the Clec2d gene; this leads to a frame-shifted transcript and the absence of a functional ectodomain (26) . We confirmed the deficiency of these Clr-b 
gcg gcc gc CTA TCC GGG ATT TAC AAT TA qClr-bF AGC TCC TCA GCT CTG AGA TGT GTG qClr-bR AGG GGA GAT GGT TCC GTG CCT TT qGAPDH-F TGT GCA GTG CCA GCC TCG TC qGAPDH-R TGA AGG GGT CGT TGA TGG CAA CA qTBP-F AGA GCC ACG GAC AAC TGC GTT G qTBP-R CTG GGA AGC CCA ACT TCT GCA C subset-restricted expression of NKR-P1B was examined in greater detail with respect to that of the self-MHC-I-specific B6 strain NK cell receptors Ly49C/I and NKG2A, on splenic and BM NK cells from WT and Clr-b 2/2 mice ( Fig. 2C, 2D ; Supplemental Fig. 1C, 1D ). Of note, NKR-P1B was enriched on self-MHC-Ispecific ("educated") NK cells expressing either Ly49C/I or NKG2A. Moreover, gating on NKR-P1B -NK cells revealed an enrichment of the classical "hyporesponsive" subset lacking expression of Ly49C/I and NKG2A; notably, however, a significant fraction of this subset did express NKR-P1B (∼30-50%), suggesting these NK cells are indeed educated and not entirely hyporesponsive, at least to MHC-independent signals. Only subtle differences were noted in the NK repertoires between WT and Clr-b 2/2 mice; specifically, fewer NKR-P1B+ cells among the hyporesponsive Ly49C -/I -/NKG2A -subset, and a corresponding increase among the Ly49C/I + subsets, were observed among Clr-b 2/2 NK cells ( Fig. 2C, 2D ; Supplemental Fig. 1C, 1D ). Similar observations were observed for NK subsets grouped according to CD94 (i.e., NKG2A/C/E) in lieu of NKG2A (Supplemental Fig. 2A-D) . Interestingly, NKR-P1B + NK cells were almost entirely 2B4 + , suggesting a cosegregation of NK cells responsive to MHCindependent ligands (Supplemental Fig. 2E-H) .
Notably, trends toward higher expression of inhibitory NK receptors (e.g., NKR-P1B, Ly49) and lower expression of stimu- . (D) Alternative gating strategy based upon NKR-P1B levels (left plot) for subsetting of splenic NK cells from B6 and Clr-b 2/2 mice, showing NKG2A and Ly49C/I expression on NKR-P1B +/2 subsets (right plots). All data are representative of at least three independent mice from each genotype. DN, double-negative, hyporesponsive subset; DP, doublepositive, educated, total SP + DP subsets; MFI, median fluorescence intensity; SP, single-positive.
latory receptors (e.g., NKp46, NKR-P1C, 2B4, NKG2D, CD94 + / NKG2A -) were observed among NK cells from Clr-b 2/2 mice (Supplemental Fig. 3 ) BM cells. Donor cohorts were labeled using different combinations of three fluorescent dyes, then transplanted stoichiometrically into untreated or NK-depleted recipients (see Materials and Methods; Table II ; Supplemental Fig. 4 ). Following transplantation (18-48 h), the various MHC-I-deficient BM donors were rejected differentially (Supplemental Fig. 4) , similar to observations reported in previous studies (36) . Notably, Clr-b 2/2 BM cells were selectively rejected in WT recipients, roughly comparable to single MHC-I-deficient H-2D b2/2 BM cells ( Fig. 3B; Supplemental Fig. 4) . Moreover, NK depletion reversed the rejection of Clr-b 2/2 and MHC-I-deficient BM cells (Fig. 3B ). In addition, Clr-b 2/2 and MHC-I-deficient splenocyte rejections mirrored the patterns observed for BM rejections, perhaps with a slightly weaker contribution of Clr-b versus H-2D b (Fig. 3C) B62/2 recipients, which are fully NK sufficient but lack the cognate NKR-P1B receptor (27) (Fig. 4C) 
recipients even following in vivo NK cell priming using polyI:C or CpG-B ODN (Fig. 4D) ) via the FcR on P815 target cells. Notably, P815 targets were susceptible to NK-LAK cells from both genotypes; however, 2D12 mAb (but not isotype control mAb) decreased cytotoxicity of P815 targets via NKR-P1B-mediated redirected inhibition on both WT and Clr-b 2/2 effectors (Fig. 5B) . Notably, redirected inhibition was not observed using sorted NKR-P1B -NK-LAK effectors (data not shown). These data confirm the intact inhibitory function of NKR-P1B, even during Clr-b 2/2 NK cell education, and suggest that Clr-b 2/2 NK cells may possess altered responsiveness to some tumor targets. (Fig. 6A) , perhaps in part owing to reduced NK1.1 expression (see Supplemental Fig. 3) . Similar results were observed in response to IL-12/IL-18 cytokine priming (Fig. 6C) . Collectively, relative to WT NK cells, Clr-b 2/2 NK cells display a hyporesponsive phenotype to NK1.1 stimulation (0.7-fold) and IL-12 cytokine priming (0.6-fold), similar to the phenotype observed for MHC-I-deficient NK cells. Of interest, differences between the NKR-P1B hi/+ and NKR-P1B lo/-NK cell subsets were not observed (Fig. 6B, 6D ), suggestive of a generalized hyporesponsiveness of Clr-b 2/2 NK cells, one that is not NKR-P1B subset restricted. 
Discussion
The importance of NK cells in determining the outcome of BM transplantation is highlighted by hybrid resistance experiments (5-8) and BM allograft acceptance in NK-depleted, but not NKsufficient, SCID mice (14) (15) (16) (17) (18) (19) . These findings have since been explained by missing-self recognition of MHC-I molecules, which are highly polymorphic. MHC-I polymorphisms in turn have influenced the convergent evolution of two highly diversified receptor families (Ly49 in mice, KIR in humans), which also exhibit multiple polymorphisms at both the allelic and gene content levels (44) . In contrast, fewer yet significant allelic polymorphisms exist in the mouse Nkrp1:Clr system (30, 44) , in which the overall haplotype structure appears to be conserved (44, 45) . Interestingly, among the Clr family, Clr-b possesses an expression pattern similar to that of MHC-I, yet demonstrates no allelic polymorphisms to date between evaluated mouse strains (B6, BALB, 129) (22) . Because loss of Clr-b has been documented in tumor, infected, and stressed cell pathological states (21, 23), we investigated the role of this MHC-independent missing-self recognition mechanism in the recognition of normal, healthy cells, using Clr-bdeficient mice and a competitive in vivo BM transplantation model (26, 41, 42, 46) . The Ocil/Clr-b 2/2 mice were previously generated by targeted deletion of exon-3 of Clec2d and display a mild defect in osteogenesis (26) . This mutation results in a smaller frame-shifted but expressed transcript. Notably, data in our laboratory reveal that some tumor lines possess endogenous exon-3-deleted Clr-b transcripts (C.L. Kirkham, unpublished observations), suggesting alternative splicing may occur naturally or in cancer. We observed that Clr-b 2/2 (but not Clr-b +/2 ) cells lack surface Clr-b protein (detected by 4A6 mAb) and functional NKR-P1B ligand (assessed by BWZ.CD3z/NKR-P1B reporters). These data suggest The steady-state immune and hematopoietic composition of Clr-b 2/2 mice showed no major differences. In addition, we observed few significant differences in NK cell receptor expression. However, significantly higher expression of the inhibitory NKR-P1B receptor was observed on BM, splenic, and hepatic NK cells from Clr-b
animals, along with significantly lower expression of stimulatory NKp46 receptor. Other trends were observed toward decreased expression of stimulatory NK receptors (NKR-P1C, 2B4, NKG2D, CD94/NKG2C/E) and perhaps slightly increased expression of inhibitory NK receptors (Ly49, CD94/NKG2A). These changes in balanced signaling are expected to elicit hyporesponsiveness. Elevated Ly49 receptor expression has been observed on NK cells from b 2 m 2/2 mice, which lack MHC-I ligands (35) . Mechanistically, elevated NKR-P1B expression is likely posttranslational and due to a lack of receptor ligation or internalization following interaction with cognate ligand (on NK cells in cis or on neighboring cells in trans) (47, 48) . Furthermore, increased NKR-P1B on Clr-b 2/2 NK cells may occur during education, as developing NK cells integrate stimulatory and inhibitory signals. To achieve balance, developing Clr-b 2/2 NK cells may augment inhibitory NKR-P1B expression and/or decrease that of stimulatory receptors. As highlighted above, Clr-b 2/2 NK cells exhibit reduced NKp46 receptor levels. NKp46 is reported to recognize an unknown self-ligand (49); thus, lowering NKp46 expression may reduce the net threshold of activation to compensate during NK cell education. Acute rejection of MHC-I-deficient hematopoietic grafts by NK cells has been widely documented (32, 36) . We developed a competitive assay to assess Clr-b 2/2 graft rejection relative to control WT and MHC-I-deficient grafts in a single mouse. This assay employs three fluorophores with distinct spectra to enable differential labeling of seven donor populations. This approach is indexed and internally controlled, and inherently conserves recipient animals and reagents, in addition to reducing variability, as competitive rejections of all donors occur simultaneously. As cell surface molecules (50) . Therefore, these transplanted grafts promote disinhibition of both Ly49 + and NKG2/CD94 + NK subsets, which synergize to mediate rejection (51 
